Search
DEEN
more info

Contact:
Phone:+49 0761 1514 440Fax:+49 0761 1514 460Email:info[at]falkfoundation.org

    Falk Gastro Review Journal

    Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

    Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

    The latest issues

    Edition 4/2024

    read more

    Edition 3/2024

    read more

    Edition 2/2024

    read more

    Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

    All articles

    Esophagus to Small Intestine

    Long-term outcomes of the excluded rectum in Crohn’s disease: A multicenter international study

    Inflamm Bowel Dis. 2023;29(3):417−22

    Kassim G, Yzet C, Nair N, Debebe A, Rendon A, Colombel JF, Traboulsi C, Rubin DT, Maroli A, Coppola E, Carvello MM, Ben David N, De Lucia F, Sacchi M, Danese S, Spinelli A, Hirdes MMC, ten Hove J, Oldenburg B, Cholapranee A, Riter M, Lukin D, Scherl E, Eren E, Sultan KS, Axelrad J, Sachar DB

    Go to article

    Esophagus to Small Intestine

    5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn’s disease: A nationwide cohort study

    Aliment Pharmacol Ther. 2023;57(9):1004−13

    Atia O, Goren I, Fischler TS, Loewenberg Weisband Y, Greenfeld S, Kariv R, Ledderman N, Matz E, Rimon RM, Dotan I, Turner D, Yanai H

    Go to article

    Colon to Rectum

    Anti-integrin αvβ6 autoantibodies are a novel biomarker that antedate ulcerative colitis

    Gastroenterology. 2023;164(4):619−29

    Livanos AE, Dunn A, Fischer J, Ungaro RC, Turpin W, Lee SH, Rui S, Del Valle DM, Jougon JJ, Martinez-Delgado G, Riddle MS, Murray JA, Laird RM, Torres J, Agrawal M, Magee JS, Dervieux T, Gnjatic S, Sheppard D, Sands BE, Porter CK, Croitoru K, Petralia F, Colombel JF, Mehandru S; CCC-GEM Project Research Consortium, OSCCAR Consortium

    Go to article

    Colon to Rectum

    Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): Two randomized, double-blind, placebo-controlled, phase 3 studies

    Lancet. 2023;401(10383):1159–71

    Sandborn WJ, Vermeire S, Peyrin-Biroulet L, Dubinsky MC, Panes J, Yarur A, Ritter T, Baert F, Schreiber S, Sloan S, Cataldi F, Shan K, Rabbat CJ, Chiorean M, Wolf DC, Sands BE, D’Haens G, Danese S, Goetsch M, Feagan BG

    Go to article

    Colon to Rectum

    Hypophosphatemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anemia due to inflammatory bowel disease (PHOSPHARE-IBD): A randomized clinical trial

    Gut. 2023;72(4):644−53

    Zoller H, Wolf M, Blumenstein I, Primas C, Lindgren S, Thomsen LL, Reinisch W, Iqbal T

    Go to article

    Colon to Rectum

    Lifestyle factors for the prevention of inflammatory bowel disease

    Gut. 2023;72:1093−100

    Lopes EW, Chan SSM, Song M, Ludvigsson JF, Håkansson N, Lochhead P, Clark A, Burke KE, Ananthakrishnan AN, Cross AJ, Palli D, Bergmann MM, Richter JM, Chan AT, Olén O, Wolk A, Khalili H; EPIC-IBD investigators

    Go to article

    Colon to Rectum

    Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): A randomized, double-blind, controlled, phase 2, proof-of-concept trial

    Lancet Gastroenterol Hepatol. 2023;8(4):307–20

    Feagan BG, Sands BE, Sandborn WJ, Germinaro M, Vetter M, Shao J, Sheng S, Johanns J, Panés J; VEGA Study Group

    Go to article

    Colon to Rectum

    Antibiotic use as a risk factor for inflammatory bowel disease across the ages: A population-based cohort study

    Gut. 2023;72(4):663–70

    Faye AS, Højgaard Allin K, Iversen AT, Agrawal M, Faith J, Colombel JF, Jess T

    Go to article

    Colon to Rectum

    Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative coli-tis

    Gastroenterology. 2023;164(7):1180−8.e2

    Iacucci M, Parigi TL, Del Amor R, Meseguer P, Mandelli G, Bozzola A, Bazarova A, Bhandari P, Bisschops R, Danese S, De Hertogh G, Ferraz JG, Goetz M, Grisan E, Gui X, Hayee B, Kiesslich R, Lazarev M, Panaccione R, Parra-Blanco A, Pastorelli L, Rath T, Røyset ES, Tontini GE, Vieth M, Zardo D, Ghosh S, Naranjo V, Villanacci V

    Go to article